Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy

Epilepsia

Volumn 42, Issue 9, 2001, Pages 1141-1147

  Guo, Chun Yuan ^a   Ronen, Gabriel M ^a,b   Atkinson, Stephanie A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Bone mineral density; Bone turnover; Epilepsy; Growth; Physical activity

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; LAMOTRIGINE; OSTEOCALCIN; PARATHYROID HORMONE; VALPROIC ACID;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BODY HEIGHT; BODY MASS; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; EPILEPSY; FEMALE; GROWTH RETARDATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADOLESCENT; ANTICONVULSANTS; BONE AND BONES; BONE DENSITY; BONE DISEASES, DEVELOPMENTAL; BONE DISEASES, METABOLIC; CALCIUM, DIETARY; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DIET; EPILEPSY; EXERTION; FEMALE; GROWTH; HUMANS; MALE; OSTEOCALCIN; TRIAZINES; VALPROIC ACID; VITAMIN D;

EID: 0034794545     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.416800.x     Document Type: Article

References (38)

1. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children
2. Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status
3. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment
4. Factors causing rickets in institutionalized handicapped children on anticonvulsant therapy
5. Mineral metabolism in poorly nourished epileptic children
6. 2
7. Increased circulating levels of γ-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy
8. Anticonvulsant drugs and vitamin D metabolism
9. Serum 25-hydroxy calciferol levels and bone mass in children on chronic anti-epileptic therapy
10. Pathophysiology behind anticonvulsant osteomalacia
11. Osteomalacia with long-term anticonvulsant therapy in epilepsy
12. The effect of anticonvulsant therapy on serum levels of 25-hydroxyvitamin D, calcium and parathyroid hormone
13. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs
14. Bone mineral density measured by dual-energy absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
15. Effect of carbamazepine and valproate on bone mineral density
16. Effect of valproate on bone mineral density
17. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years
18. Evaluation of bone mineral density in children receiving antiepileptic drugs
19. Strategies to protect bone mass in the older patients with epilepsy
20. Drug-induce osteomalacia
21. The effects of valproate, Carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy
22. Adolescents self-assessment of sexual maturation
23. Comparison of nutrient intake determined by four dietary intake instruments
24. Development and testing of the Habitual Activity Estimation Scale
25. Bone densitometry in Canadian children 8-17 years old
26. Total body bone mineral density in young children: Influence of head bone mineral density
27. Physical growth: National Center for Health Statistic percentile
28. Serum osteocalcin in 1634 healthy children
29. Serum biochemical markers of bone turnover in healthy infants and children
30. An improved method for routine determination of vitamin D and its hydroxylated metabolites in serum from children and adults
31. Moderate exercise during growth in prepubertal boys: Changes in bone mass, size, volumetric density, and bone strength: A controlled prospective study
32. Influence of heredity and environment on bone density in adolescent boys: A parent-offspring study
33. Effect of exercise and exogenous glucocorticoid on serum level of intact parathyroid hormone
34. Bone mass and endocrine adaptations to training in spinal cord injured individuals
35. Osteoporosis in elderly men and women: Effects of dietary calcium, physical activity, and body mass index
36. Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsont medication
37. Delayed bone development in epileptic children assessed by microdensitometer